Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Purpose. A pooled analysis of six clinical studies was conducted to describe the pharmacokinetics of extended-release epidural morphine sulfate. Methods. Data from six clinical studies evaluating ...

A groundbreaking study suggests that IBS might be more of a brain issue than a gut disorder. Researchers found that ...

An international team of researchers, led by the University of Glasgow, hopes to find new ways to target opioid addiction ...

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global ...

The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

Background: Fentanyl, a short-acting synthetic opioid, has a pharmacokinetic ... to rescue medication were also recorded. Results: The pharmacokinetics of intravenous fentanyl reflected a 2 ...

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, ...

Irritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and changes in bowel habits, including diarrhea, ...

Antidotes are critical in toxicology, offering therapeutic solutions to poisoning by neutralizing toxins and enhancing the ...